21 May 2009
Mid-term results of endovascular treatment of abdominal aortic aneurysm in kidney transplant recipients
J Szmidt, Z Gałązka, O Rowiński, T Jakimowicz, M Durlik, Ł Romanowski, B SolonynkoAnn Transplant 2009; 14(1): 47-47 :: ID: 880369
Abstract
Background: The number of abdominal aortic aneurysms (AAA) in kidney
transplant recipients is increasing. Previously performed open aneurysmectomy is technically difficult and burdened with high risk of ischemic injury to transplanted kidney. The aim of the study was to assess the results of endovascular AAA treatment in kidney transplant recipients.
Material/Methods: Since 1998 endovascular treatment of AAA was performed in 665 patients in our Department. Eleven (1.65%) were kidney transplant recipients. Time between kidney transplantation and AAA management was 3 to 19 years. In 7 patients' graft's renal artery was anastomosed by end-to-end method to hypogastric artery, in remaining patients' end-to-side to external iliac artery. Bifurcated stent-grafts were implanted under epidural anaesthesia. All patients were followed-up with Doppler ultrasound or CT-scan performed according to Eurostar protocol. Kidney function was assessed two to four times a year.
Results: Successful AAA exclusion and preserved flow to transplanted kidney were confirmed on the final angiogram in all patients. Temporary deterioration of transplanted kidney function was observed in three patients, one of them required transient haemodialysis. In follow-up there was one stent-graft's limb thrombosis at 9 months after stent-graft's implantation that required femoro-femoral by-pass. In two patients there was endoleak type I treated successfully with proximal extension. The mean observation period was 34 months (range 3-80 months).
Conclusions: Endovascular treatment of AAA in kidney transplant recipients can be performed without major complications and serious deterioration of graft function. Thus this is a safe and effective method and can be considered as a treatment of choice.
Keywords: Kidney Transplantation
In Press
Original article
Diagnostic Utility of FAR1 Methylation Levels in Hepatocellular Carcinoma Patients Undergoing Liver Transpl...Ann Transplant In Press; DOI: 10.12659/AOT.951568
Original article
Inferior Long-Term Outcome of Fatty Liver Allografts After Orthotopic Liver TransplantationAnn Transplant In Press; DOI: 10.12659/AOT.950589
Database Analysis
Identification and Validation of Liver Transplantation-Induced Acute Lung Injury Biomarkers Using a Bioinfo...Ann Transplant In Press; DOI: 10.12659/AOT.950289
Original article
Survival and Recurrence in Liver Transplant Patients With Intrahepatic Cholangiocarcinoma and Hepatocellula...Ann Transplant In Press; DOI: 10.12659/AOT.950997
Most Viewed Current Articles
24 Aug 2021 : Review article 18,372
Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future PerspectivesDOI :10.12659/AOT.931664
Ann Transplant 2021; 26:e931664
05 Apr 2022 : Original article 14,731
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
22 Nov 2022 : Original article 14,244
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
29 Dec 2021 : Original article 13,752
Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...DOI :10.12659/AOT.933588
Ann Transplant 2021; 26:e933588






